Baxter (NYSE: BAX) reported Q1 EPS of $0.55, $0.07 better than the analyst estimate of $0.48. Revenue for the quarter came in at $2.63 billion versus the consensus estimate of $2.59 billion.

GUIDANCE:

Baxter sees Q2 2025 EPS of $0.59-$0.63, versus the consensus of $0.61.

Baxter sees FY2025 EPS of $2.47-$2.55, versus the consensus of $2.49.

For earnings history and earnings-related data on Baxter (BAX) click here.